Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Onosereme Ofoman"'
Autor:
Trenton Reinicke, Justin F. Gainor, Marissa N Bruno, Henning Willers, Erika Nakajima, Anand S. Dighe, Yi-Bin Chen, Vivek Naranbhai, Leyre Zubiri, Aleigha Lawless, Brittany Y Bertaux, Aditya Bardia, Kerry L. Reynolds, Rebecca R. Saff, Jocelyn R. Farmer, Kerri St. Denis, A. John Iafrate, Elizabeth Niehoff, Joan How, Mustafa Sakhi, Grace Kirkpatrick, Arthur Y. Kim, Wilfredo-Garcia Beltran, Alejandro B. Balazs, Alexander Gavralidis, Caroline Barabell, Monica A Jackson, C. Bowes, Lailoo A Perriello, Amir T. Fathi, Andrew M. Brunner, Evan C. Lam, Gabriela S. Hobbs, Grace Hambelton, Christian N Nambu, Kimberly G. Blumenthal, Julia Thierauf, Laura Spring, Elyssa Denault, Claire A. Pernat, Steven J. Isakoff, Ryan J. Sullivan, Cristhian J Berrios-Mairena, Jennifer L Peterson, Lindsey Mortensen, Onosereme Ofoman
Publikováno v:
Journal of Clinical Oncology. 40:12-23
PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood. METHODS We performed a prospective cohort study of adults with solid-organ or hematologic cancers to evaluate anti–SARS-CoV-2 immuno
Autor:
Vivek Naranbhai, Anusha Nathan, Clarety Kaseke, Cristhian Berrios, Ashok Khatri, Shawn Choi, Matthew A. Getz, Rhoda Tano-Menka, Onosereme Ofoman, Alton Gayton, Fernando Senjobe, Kerri J. St Denis, Evan C. Lam, Wilfredo F. Garcia-Beltran, Alejandro B. Balazs, Bruce D. Walker, A. John Iafrate, Gaurav D. Gaiha
Publikováno v:
medRxiv
The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from infection and vaccine-induced antibody responses, although the extent to which these substitutions in spike and non-spike proteins affect T cell recognition is unk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0dbfe84f2f53c41065f394c786fd72e
https://doi.org/10.1101/2022.01.04.21268586
https://doi.org/10.1101/2022.01.04.21268586
Autor:
Vivek Naranbhai, Kerri J. St. Denis, Evan C. Lam, Onosereme Ofoman, Wilfredo F. Garcia-Beltran, Cristhian B. Mairena, Atul K. Bhan, Justin F. Gainor, Alejandro B. Balazs, A. John Iafrate, Ryan J. Sullivan, Aditya Bardia, Laura M. Spring, Steven J. Isakoff, Jocelyn R. Farmer, Leyre Zubiri, Gabriella S. Hobbs, Joan How, Andrew M. Brunner, Amir T. Fathi, Clarie A. Pernat, A. Gavralidis, Jennifer L. Peterson, Mustafa Sakhi, Grace Hambelton, Elyssa N. Denault, Lindsey J. Mortensen, Lailoo A. Periello, Marissa N. Bruno, M.N. Bruno, Brittany Y. Betraux, Alyssa R. Lawless, Melissa A. Jackson, Elizabeth Niehoff, Claire Barabell, Christain N. Nambu, Erika Nakajima, Thomas Reinecke, Cyndi Bowes, Grace E. Kirkpatrick, Julia C. Thierauf, Kerri Reynolds, Henning Willers, Anand S. Dighe, Rebecca Saff, Kimberley Blumenthal
Publikováno v:
Cancer Cell
Patients with cancer are more likely to have impaired immune responses to SARS-CoV-2 vaccines. We study the breadth of responses against SARS-CoV-2 variants after primary vaccination in 178 patients with a variety of tumor types and after booster dos
Autor:
Cory A. Perugino, Hang Liu, Jared Feldman, Blake M. Hauser, Catherine Jacob-Dolan, Anusha Nathan, Zezhou Zhou, Clarety Kaseke, Rhoda Tano-Menka, Matthew A. Getz, Fernando Senjobe, Cristhian Berrios, Onosereme Ofoman, Jacob E. Lemieux, Marcia B. Goldberg, Kerstin Nundel, Ann Moormann, Ann Marshak-Rothstein, John A. Iafrate, Gaurav Gaiha, Richelle Charles, Alejandro B. Balazs, Vivek Naranbhai, Aaron G. Schmidt, Shiv Pillai
In previously unvaccinated and uninfected individuals, non-RBD SARS-CoV-2 spike-specific B cells were prominent in two distinct, durable, resting, cross-reactive, “pre-existing” switched memory B cell compartments. While pre-existing RBD-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c444d4ac65de427e25dddb2163451afc
https://doi.org/10.1101/2021.12.30.21268554
https://doi.org/10.1101/2021.12.30.21268554
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Autor:
Wilfredo F. Garcia-Beltran, Kerri J. St. Denis, Angelique Hoelzemer, Evan C. Lam, Adam D. Nitido, Maegan L. Sheehan, Cristhian Berrios, Onosereme Ofoman, Christina C. Chang, Blake M. Hauser, Jared Feldman, Alex L. Roederer, David J. Gregory, Mark C. Poznansky, Aaron G. Schmidt, A. John Iafrate, Vivek Naranbhai, Alejandro B. Balazs
Publikováno v:
Cell
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of neutralizing antibodies. Given its potential to escape vaccine-induced humoral immunity, we
Autor:
Kerri St. Denis, Cristhian Berrios, Onosereme Ofoman, Justin F. Gainor, Alejandro B. Balazs, Vivek Naranbhai, Evan C. Lam, Wilfredo-Garcia Beltran, Atul K. Bhan, A. John Iafrate
SummaryPatients with cancer are more likely to have impaired immune responses to SARS CoV-2 vaccines. We studied the breadth of responses against SARS CoV-2 variants followingly primary vaccination in 178 patients with a variety of tumor types, and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::866887f6d882c39eb26280e596a93563
https://doi.org/10.1101/2021.11.10.21265988
https://doi.org/10.1101/2021.11.10.21265988
Autor:
Sara Barmettler, Daniel V. DiGiacomo, Nancy J. Yang, Tiffany Lam, Vivek Naranbhai, Anand S. Dighe, Kristin E. Burke, Kimberly G. Blumenthal, Morris Ling, Paul E. Hesterberg, Rebecca R. Saff, James MacLean, Onosereme Ofoman, Cristhian Berrios, Kerri J. St Denis, Evan C. Lam, David Gregory, Anthony John Iafrate, Mark Poznansky, Hang Lee, Alejandro Balazs, Shiv Pillai, Jocelyn R. Farmer
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 10:1622-1634.e4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with predominant antibody deficiency (PAD) is associated with high morbidity, yet data regarding the response to SARS-CoV-2 immunization in PAD patients, including add
mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant
Autor:
Wilfredo F. Garcia-Beltran, Kerri J. St. Denis, Angelique Hoelzemer, Evan C. Lam, Adam D. Nitido, Maegan L. Sheehan, Cristhian Berrios, Onosereme Ofoman, Christina C. Chang, Blake M. Hauser, Jared Feldman, David J. Gregory, Mark C. Poznansky, Aaron G. Schmidt, A. John Iafrate, Vivek Naranbhai, Alejandro B. Balazs
Publikováno v:
medRxiv
SUMMARYRecent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of vaccine-induced neutralizing antibodies. Given its potential to escape vaccine-induc